Envveno Medical Corp Stock Today
| NVNO Stock | USD 2.82 0.09 3.09% |
Performance0 of 100
| Odds Of DistressLess than 24
|
EnVVeno Medical is selling at 2.82 as of the 25th of December 2024; that is 3.09% down since the beginning of the trading day. The stock's open price was 2.91. EnVVeno Medical has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of December 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 31st of May 2018 | Category Healthcare | Classification Health Care |
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company was formerly known as Hancock Jaffe Laboratories, Inc. The company has 17.54 M outstanding shares of which 479.08 K shares are now shorted by private and institutional investors with about 4.12 trading days to cover. More on enVVeno Medical Corp
Moving against EnVVeno Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
EnVVeno Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
enVVeno Medical Corp (NVNO) is traded on NASDAQ Exchange in USA. It is located in 70 Doppler, Irvine, CA, United States, 92618 and employs 31 people. EnVVeno Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 51.03 M. enVVeno Medical Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 17.54 M outstanding shares of which 479.08 K shares are now shorted by private and institutional investors with about 4.12 trading days to cover.
enVVeno Medical Corp currently holds about 37.48 M in cash with (18.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check EnVVeno Medical Probability Of Bankruptcy
Ownership AllocationEnVVeno Medical holds a total of 17.54 Million outstanding shares. Nearly 69.94 percent of EnVVeno Medical outstanding shares are held by general public with 0.3 (percent) owned by insiders and only 29.76 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check EnVVeno Ownership Details
EnVVeno Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Corsair Capital Management Llc | 2024-09-30 | 116 K | |
| Hudson Bay Capital Management Lp | 2024-09-30 | 93.2 K | |
| Hohimer Wealth Management, Llc | 2024-09-30 | 85 K | |
| Blackrock Inc | 2024-06-30 | 39.5 K | |
| Westside Investment Management, Inc. | 2024-06-30 | 38.8 K | |
| Northern Trust Corp | 2024-09-30 | 33.7 K | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 33.2 K | |
| Fermata Advisors, Llc | 2024-09-30 | 30.2 K | |
| State Street Corp | 2024-09-30 | 26.5 K | |
| Kingdon Capital Management Llc | 2024-09-30 | 859.3 K | |
| Perceptive Advisors Llc | 2024-09-30 | 694.3 K |
enVVeno Medical Corp Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. EnVVeno Medical market risk premium is the additional return an investor will receive from holding EnVVeno Medical long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | (0.79) |
EnVVeno Stock Against Markets
EnVVeno Medical Corporate Management
| Andrew Cormack | Chief Officer | Profile | |
| Craig Glynn | Treasurer CFO | Profile | |
| Benedict MD | Chief States | Profile | |
| Sandy Prietto | Vice Marketing | Profile | |
| Robert Berman | CEO Director | Profile | |
| Marc MD | Senior Officer | Profile | |
| Hamed Alavi | Senior Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Return On Assets (0.37) | Return On Equity (0.59) |
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.